Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform

Current Opinion in Virology

Volumn 11, Issue , 2015, Pages 76-82

  O'Rourke, John P ^a   Peabody, David S ^a   Chackerian, Bryce ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; BACTERIOPHAGE VIRUS LIKE PARTICLE VACCINE; EPITOPE; MIMOTOPE; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE;

ANTIBODY AFFINITY; ANTIBODY LABELING; ANTIBODY RESPONSE; ARTICLE; BACTERIOPHAGE; DRUG ANTIGENICITY; EPITOPE MAPPING; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PEPTIDE LIBRARY; PHAGE DISPLAY; PRIORITY JOURNAL; SURFACE PROPERTY; VACCINATION; VACCINE PRODUCTION; CELL SURFACE DISPLAY; DRUG DEVELOPMENT; GENETICS; IMMUNOLOGY; PROCEDURES;

BACTERIOPHAGES; CELL SURFACE DISPLAY TECHNIQUES; DRUG DISCOVERY; EPITOPES; HUMANS; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84925878613     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2015.03.005     Document Type: Review

References (41)

1. G.T. Jennings, and M.F. Bachmann The coming of age of virus-like particle vaccines Biol Chem 389 2008 521 536
2. F. Zabel, T.M. Kundig, and M.F. Bachmann Virus-induced humoral immunity: on how B cell responses are initiated Curr Opin Virol 3 2013 357 362
3. M. Brunswick, F.D. Finkelman, P.F. Highet, J.K. Inman, H.M. Dintzis, and J.J. Mond Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation J Immunol 140 1988 3364 3372
4. R.Z. Dintzis, M.H. Middleton, and H.M. Dintzis Inhibition of anti-DNP antibody formation by high doses of DNP-polyacrylamide molecules; effects of hapten density and hapten valence J Immunol 135 1985 423 427
5. D.R. Milich, M. Chen, F. Schodel, D.L. Peterson, J.E. Jones, and J.L. Hughes Role of B cells in antigen presentation of the hepatitis B core Proc Natl Acad Sci USA 94 1997 14648 14653
6. B. Chackerian, M.R. Durfee, and J.T. Schiller Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model J Immunol 180 2008 5816 5825
7. A. Jegerlehner, T. Storni, G. Lipowsky, M. Schmid, P. Pumpens, and M.F. Bachmann Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation Eur J Immunol 32 2002 3305 3314
8. B. Chackerian, P. Lenz, D.R. Lowy, and J.T. Schiller Determinants of autoantibody induction by conjugated papillomavirus virus-like particles J Immunol 169 2002 6120 6126
9. R.Z. Dintzis, B. Vogelstein, and H.M. Dintzis Specific cellular stimulation in the primary immune response: experimental test of a quantized model Proc Natl Acad Sci USA 79 1982 884 888
10. I.J. Amanna, and M.K. Slifka Mechanisms that determine plasma cell lifespan and the duration of humoral immunity Immunol Rev 236 2010 125 138
11. J.T. Schiller, and D.R. Lowy Raising expectations for subunit vaccine J Infect Dis 2014 10.1093/infdis/jiu648 [Epub ahead of print]
12. B. Chackerian Virus-like particles: flexible platforms for vaccine development Expert Rev Vaccines 6 2007 381 390
13. L.H. Lua, N.K. Connors, F. Sainsbury, Y.P. Chuan, N. Wibowo, and A.P. Middelberg Bioengineering virus-like particles as vaccines Biotechnol Bioeng 111 2014 425 440
14. N. Schmitz, R.R. Beerli, M. Bauer, A. Jegerlehner, K. Dietmeier, M. Maudrich, P. Pumpens, P. Saudan, and M.F. Bachmann Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection Eur J Immunol 42 2012 863 869
15. E. Tumban, J. Peabody, D.S. Peabody, and B. Chackerian A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants Vaccine 31 2013 4647 4654
16. P. Maurer, and M.F. Bachmann Immunization against angiotensins for the treatment of hypertension Clin Immunol 134 2010 89 95
17. A.C. Tissot, P. Maurer, J. Nussberger, R. Sabat, T. Pfister, S. Ignatenko, H.D. Volk, H. Stocker, P. Muller, and G.T. Jennings Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study Lancet 371 2008 821 827
18. J. Cornuz, S. Zwahlen, W.F. Jungi, J. Osterwalder, K. Klingler, G. van Melle, Y. Bangala, I. Guessous, P. Muller, and J. Willers A vaccine against nicotine for smoking cessation: a randomized controlled trial PLoS One 3 2008 e2547
19. D.S. Peabody Subunit fusion confers tolerance to peptide insertions in a virus coat protein Arch Biochem Biophys 347 1997 85 92
20. C. Caldeira Jdo, A. Medford, R.C. Kines, C.A. Lino, J.T. Schiller, B. Chackerian, and D.S. Peabody Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7 Vaccine 28 2010 4384 4393
21. B. Chackerian, C. Caldeira Jdo, J. Peabody, and D.S. Peabody Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles J Mol Biol 409 2011 225 237
22. D.S. Peabody, B. Manifold-Wheeler, A. Medford, S.K. Jordan, J. do Carmo Caldeira, and B. Chackerian Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2 J Mol Biol 380 2008 252 263
23. E. Tumban, J. Peabody, D.S. Peabody, and B. Chackerian A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein L2 PLoS ONE 6 2011 e23310
24. D.S. Peabody Translational repression by bacteriophage MS2 coat protein expressed from a plasmid. A system for genetic analysis of a protein-RNA interaction J Biol Chem 265 1990 5684 5689
25. J.N. Billaud, D. Peterson, M. Barr, A. Chen, M. Sallberg, F. Garduno, P. Goldstein, W. McDowell, J. Hughes, and J. Jones Combinatorial approach to hepadnavirus-like particle vaccine design J Virol 79 2005 13656 13666
26. W.C. Koff, D.R. Burton, P.R. Johnson, B.D. Walker, C.R. King, G.J. Nabel, R. Ahmed, M.K. Bhan, and S.A. Plotkin Accelerating next-generation vaccine development for global disease prevention Science 340 2013 1232910
27. D.R. Burton, P. Poignard, R.L. Stanfield, and I.A. Wilson Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses Science 337 2012 183 186
28. J.S. McLellan, B.E. Correia, M. Chen, Y. Yang, B.S. Graham, W.R. Schief, and P.D. Kwong Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus J Mol Biol 409 2011 853 866
29. G. Ofek, F.J. Guenaga, W.R. Schief, J. Skinner, D. Baker, R. Wyatt, and P.D. Kwong Elicitation of structure-specific antibodies by epitope scaffolds Proc Natl Acad Sci USA 107 2010 17880 17887
30. B.E. Correia, J.T. Bates, R.J. Loomis, G. Baneyx, C. Carrico, J.G. Jardine, P. Rupert, C. Correnti, O. Kalyuzhniy, and V. Vittal Proof of principle for epitope-focused vaccine design Nature 507 2014 201 206
31. A.B. Riemer, and E. Jensen-Jarolim Mimotope vaccines: epitope mimics induce anti-cancer antibodies Immunol Lett 113 2007 1 5
32. M.B. Irving, O. Pan, and J.K. Scott Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics Curr Opin Chem Biol 5 2001 314 324
33. N.E. Van Houten, and J.K. Scott Phage libraries for developing antibody-targeted diagnostics and vaccines S. Sidhu, Phage Display in Biotechnology and Drug Discovery 2005 Taylor and Francis Group Boca Raton, FL 165 254
34. M.B. Irving, L. Craig, A. Menendez, B.P. Gangadhar, M. Montero, N.E. van Houten, and J.K. Scott Exploring peptide mimics for the production of antibodies against discontinuous protein epitopes Mol Immunol 47 2010 1137 1148
35. R.L. Ord, J.C. Caldeira, M. Rodriguez, A. Noe, B. Chackerian, D.S. Peabody, G. Gutierrez, and C.A. Lobo A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein Malar J 13 2014 326
36. J.P. O'Rourke, S.M. Daly, K.D. Triplett, D. Peabody, B. Chackerian, and P.R. Hall Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway PLoS One 9 2014 e111198
37. R.N. Kirchdoerfer, A.L. Garner, C.E. Flack, J.M. Mee, A.R. Horswill, K.D. Janda, G.F. Kaufmann, and I.A. Wilson Structural basis for ligand recognition and discrimination of a quorum-quenching antibody J Biol Chem 286 2011 17351 17358
38. J. Pande, M.M. Szewczyk, and A.K. Grover Phage display: concept, innovations, applications and future Biotechnol Adv 28 2010 849 858
39. H. Melzer, K. Baier, F. Felici, B.U. von Specht, G. Wiedermann, H. Kollaritsch, U. Wiedermann, and M. Duchene Humoral immune response against proteophosphoglycan surface antigens of Entamoeba histolytica elicited by immunization with synthetic mimotope peptides FEMS Immunol Med Microbiol 37 2003 179 183
40. A. Sharma, A. Saha, S. Bhattacharjee, S. Majumdar, and S.K. Das Gupta Specific and randomly derived immunoactive peptide mimotopes of mycobacterial antigens Clin Vaccine Immunol 13 2006 1143 1154
41. A.W. Zuercher, S.M. Miescher, M. Vogel, M.P. Rudolf, M.B. Stadler, and B.M. Stadler Oral anti-IgE immunization with epitope-displaying phage Eur J Immunol 30 2000 128 135